SAA1 and ovarian cancer: In vivo validation using a C57BL/6 mouse peritoneal tumor model confirmed that SAA1 promotes the development of a tumor-promoting immunosuppressive microenvironment that facilitates the formation of ovarian cancer-associated ascites.